Management Review is a periodic, systematic evaluation by top management of the quality management system to ensure its continuing suitability, adequacy, effectiveness, and alignment with the organization's strategic direction.
Complete Guide to Management Review
Management Review is a formal, recurring process required by ISO 13485 and other quality standards where an organization's top management evaluates the performance and effectiveness of the Quality Management System (QMS). These structured meetings ensure that the QMS remains appropriate for the organization's needs, adequately addresses regulatory requirements, and effectively delivers safe, compliant medical devices.
Regulatory and standards requirements:
ISO 13485:2016 Clause 5.6 - Management Review:
ISO 13485 mandates that top management review the organization's QMS at planned intervals to ensure continuing suitability, adequacy, and effectiveness. The standard requires:
- Reviews conducted at defined intervals (at minimum annually, but often quarterly or semi-annually)
- Documented procedures for management review
- Review includes assessment of opportunities for improvement and need for changes to QMS
- Records maintained of management review meetings
FDA Quality System Regulation 21 CFR 820.20(b):
While not explicitly called "management review," FDA QSR requires management with executive responsibility to review the suitability and effectiveness of the quality system at defined intervals, ensuring it meets requirements and the organization's quality policy.
EU MDR Annex IX:
Notified Body audits verify that top management reviews the QMS to ensure continuing effectiveness and compliance with MDR requirements.
Purpose and objectives:
Management Review serves multiple critical functions:
- Verify QMS continues to meet ISO 13485, regulatory, and customer requirements
- Assess overall effectiveness in achieving quality objectives
- Identify opportunities for improvement and innovation
- Ensure adequate resources allocated to quality and regulatory compliance
- Review changing regulatory landscape and update strategies
- Demonstrate top management commitment to quality
- Align QMS performance with business strategy
- Address systemic issues identified through audits, complaints, or nonconformances
- Make strategic decisions about product portfolio, market expansion, or process changes
Required inputs to Management Review:
ISO 13485 specifies minimum inputs that must be considered:
- 1Audit Results
- 1Customer Feedback
- 1Process Performance and Product Conformity
- 1Status of Preventive and Corrective Actions
- 1Follow-up Actions from Previous Management Reviews
- 1Changes Affecting QMS
- 1Recommendations for Improvement
- 1New or Revised Regulatory Requirements
- 1Post-Market Surveillance Data
- 1Risk Management Review
Required outputs from Management Review:
Management review must produce documented decisions and actions including:
- 1Improvement of QMS Effectiveness
- 1Improvement Related to Regulatory Requirements
- 1Resource Needs
- 1Changes to Quality Policy and Objectives
- 1Action Items with Assignments
Management Review meeting structure:
Frequency:
- Minimum annually per ISO 13485, but best practice is quarterly or semi-annually
- More frequent reviews during periods of significant change
- Ad-hoc reviews for urgent quality or regulatory issues
Attendees:
- Top management (CEO, President, General Manager)
- Quality/Regulatory Affairs leadership
- Operations/Manufacturing management
- Research & Development leadership
- Clinical Affairs (when applicable)
- Post-Market Surveillance lead
- Others as relevant to agenda topics
Typical agenda:
1. Review of previous meeting action items
2. Overview of QMS performance metrics
3. Internal and external audit results
4. Customer feedback and complaint analysis
5. CAPA status and effectiveness
6. Nonconformance trends
7. Post-market surveillance and vigilance data
8. Regulatory update and compliance status
9. Process performance and product quality
10. Resource needs and allocation
11. Opportunities for improvement
12. New action items and assignments
Documentation requirements:
Management review records must include:
- Meeting date, attendees, and duration
- All inputs reviewed with supporting data
- Discussions and deliberations
- Decisions made by management
- Action items with responsible parties and due dates
- Approval signatures from top management
- Distribution of minutes to relevant personnel
Best practices for effective Management Review:
Preparation:
- Distribute pre-read materials 1-2 weeks in advance
- Collect data and metrics from all relevant departments
- Prepare executive summaries highlighting key trends
- Use visual dashboards and charts for clarity
- Pre-identify critical issues requiring decisions
Execution:
- Allocate sufficient time (2-4 hours minimum)
- Focus on strategic and systemic issues, not operational details
- Encourage open discussion and diverse perspectives
- Make concrete decisions, not just observations
- Assign clear ownership and deadlines for actions
- Avoid information overload; prioritize critical topics
Follow-up:
- Distribute minutes within one week
- Track action items in centralized system
- Schedule progress check-ins between reviews
- Verify completion and effectiveness of actions
- Carry forward incomplete items to next review
Common pitfalls to avoid:
- Treating management review as a "check-the-box" compliance exercise
- Insufficient preparation or incomplete data
- Focus on positive news while avoiding difficult issues
- Lack of top management engagement or attendance
- No actionable decisions or resource commitments
- Failure to follow up on previous action items
- Inadequate documentation of discussions and decisions
Integration with other QMS processes:
Management Review connects to virtually all QMS elements:
- Internal Audit - Audit findings inform management review; review decisions may trigger audits
- CAPA - CAPA metrics reviewed; management decisions may initiate CAPAs
- Risk Management - Product and process risks assessed; resources allocated for risk mitigation
- Training - Training effectiveness reviewed; new training needs identified
- Design Control - New product performance reviewed; development resources allocated
- Post-Market Surveillance - Market data reviewed; field actions and vigilance assessed
- Supplier Management - Supplier performance reviewed; supplier development decisions made
Metrics commonly reviewed:
- Customer complaint rate and trends
- CAPA closure rate and overdue aging
- Internal audit findings by severity
- Nonconformance rate and scrap costs
- On-time delivery performance
- First-pass yield percentages
- Training completion rates
- Regulatory submission timelines
- Post-market surveillance metrics
- Customer satisfaction scores
Effective Management Review ensures that top leadership remains engaged with QMS performance, makes informed strategic decisions, allocates resources appropriately, and maintains a culture of quality and continuous improvement essential for medical device regulatory compliance and patient safety.
Related Terms
More Compliance & Standards
View allThe FDA's Quality System Regulation (QSR) that establishes current Good Manufacturing Practice (cGMP) requirements for medical device manufacturers in the United States.
A systematic, independent examination of a Quality Management System to determine whether quality activities and results comply with planned arrangements and whether these arrangements are implemented effectively.
A systematic approach to investigating, correcting, and preventing quality problems in medical device manufacturing and operations.
A mandatory conformity marking for medical devices sold in the European Economic Area, indicating compliance with EU health, safety, and environmental requirements.
Need Help with Global Registration?
Pure Global provides regulatory consulting and AI-powered tools to help medical device companies navigate Global market access.

